Trademark Search in Canada

ZILQIVIK

View On IC.GC.CA

ADVERTISED

on 10 Jan 2025

Last Applicant/ Owned by

UCB BIOPHARMA SRL

Allée de la Recherche 60B-1070 Brussels,

Serial Number

2160303 filed on 14^th Jan 2022

Registration Number

TMA1282545 registered on 10^th Jan 2025

Registration expiry Date

10^th Jan 2035

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

H3B1S6

ZILQIVIK

Trademark usage description

pharmaceutical preparations and substances for the treatment of immunology diseases and disorders and neurology diseases and disorders, namely myasthe Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of immunology diseases and disorders and neurology diseases and disorders, namely myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies, diseases and disorders of the central nervous system namely brain, movement, ocular motility and spinal cord diseases.

Classification kind code

Mark Details

Serial Number

2160303

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 23^rd Oct 2024	Advertised
Submitted for opposition 26 on 27^th Sept 2024	Approved
Submitted for opposition 27 on 27^th Sept 2024	Approval Notice Sent
Submitted for opposition 22 on 19^th Jan 2024	Search Recorded
Submitted for opposition 20 on 19^th Jan 2024	Examiner's First Report
Submitted for opposition 67 on 15^th Dec 2023	Agent Name Changed
Submitted for opposition 287 on 13^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 14^th Jan 2022	Filed
Submitted for opposition 1 on 14^th Jan 2022	Created
Submitted for opposition 31 on 14^th Jan 2022	Formalized